Author:
Spasić Ana,Catić-Đorđević Aleksandra,Veličković-Radovanović Radmila,Stefanović Nikola,Džodić Predrag,Cvetković Tatjana
Funder
Ministarstvo Prosvete, Nauke i Tehnološkog Razvoja
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmaceutical Science,Pharmacology,Toxicology,Pharmacy
Reference44 articles.
1. Halloran PF. Immunosuppressive drugs for kidney transplantation. N Engl J Med. 2004;351(26):2715–29.
2. Kamińska J, Głyda M, Sobiak J, Chrzanowska M. Pharmacokinetics of mycophenolic acid and its phenyl glucuronide metabolite in kidney transplant recipients with renal impairment. Arch Med Sci. 2012;8(1):88–96.
3. Patel CG, Ogasawara K, Akhlaghi F. Mycophenolic acid glucuronide (MPAG) is transported by multidrug resistance-associated protein 2 (MRP2) and this transport is not inhibited by cyclosporine, tacrolimus or sirolimus. Xenobiotica. 2013;43(3):229–35.
4. Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group. KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant. 2009;9(Suppl 3):S1–155.
5. Dobbels F, Moons P, Abraham I, Larsen CP, Dupont L, De Geest S. Measuring symptom experience of side-effects of immunosuppressive drugs: the Modified Transplant Symptom Occurrence and Distress Scale. Transpl Int. 2008;21(8):764–73.
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献